Concepedia
Statistics
Publications
30
Citations
1K
H-Index
19
Active since
1980
Affiliations
AstraZeneca (Sweden)(Current)
Lund University
University of Calgary
Institute of Biocybernetics and Biomedical Engineering
Karolinska Institutet
Anna Miller‐Larsson is an author at AstraZeneca (Sweden) specializing in medicine, lung inflammation, and inflammation.
Top concepts
MedicineLung InflammationInflammationImmunologyPhysiologyPharmacologyInflammatory Lung DiseaseAsthmaAllergyCell Biology
Publications per year
1980–2019
Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue.
Anna Miller‐Larsson, H. Mattsson, Elisabeth Hjertberg et al. · PubMed · 1998 · 144 citations
Novel Mechanism, Lung Deposition, Lung Inflammation +13
Prolonged Airway Activity and Improved Selectivity of Budesonide Possibly Due to Esterification
Anna Miller‐Larsson, Paul Jansson, Anna Runström et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 81 citations
Asthma, Inflammation, Anti-inflammatory +15
Altered lung function relates to inflammation in an acute LPS mouse model
Hanna Falk Håkansson, Amir Smailagic, Charlott Brunmark et al. · Pulmonary Pharmacology & Therapeutics · 2012 · 66 citations
Asthma, Inflammation, Altered Lung Function +11
An inhaled dose of budesonide induces genes involved in transcription and signaling in the human airways: enhancement of anti‐ and proinflammatory effector genes
Richard Leigh, Mahmoud Mostafa, Elizabeth M. King et al. · Pharmacology Research & Perspectives · 2016 · 59 citations · Full text
Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses
Yury A. Bochkov, William W. Busse, Rebecca Brockman‐Schneider et al. · Respiratory Research · 2013 · 55 citations · Full text
Viral Replication, Molecular Virology, Pathogenesis +8
1–5 of 30